VIMTALABS Intraday Analysis...

VIMTALABS Share Price

Open 211.00 Change Price %
High 211.00 1 Day 3.65 1.79
Low 197.75 1 Week -4.70 -2.21
Close 208.00 1 Month 187.00 890.48
Volume 11430 1 Year 187.00 890.48
52 Week High 219.65
52 Week Low 181.70
VIMTALABS Important Levels
Resistance 2 220.28
Resistance 1 215.22
Pivot 205.58
Support 1 200.78
Support 2 195.72
NSE INDIA Most Active Stocks
PNB 117.30 0.64%
RCOM 28.00 0.54%
FORTIS 155.50 1.24%
GMRINFRA 17.30 -1.98%
JPASSOCIAT 16.65 -0.60%
SBIN 273.30 1.35%
SUZLON 12.90 -1.15%
SUNPHARMA 525.75 -6.03%
IDBI 70.30 5.79%
HDIL 49.15 -4.47%
More..
NSE INDIA Top Gainers Stocks
UVSL 0.25 25.00%
EIHAHOTELS 519.60 20.00%
SATHAISPAT 21.15 10.44%
TCIFINANCE 28.65 10.40%
RAJVIR 47.20 9.77%
USHAMART 23.25 9.41%
SCHNEIDER 111.30 8.69%
LTTS 1367.45 8.25%
SEQUENT 80.10 8.24%
GRUH 545.75 7.67%
More..
NSE INDIA Top Losers Stocks
FCSSOFT 0.40 -11.11%
NAKODA 0.40 -11.11%
GITANJALI 27.40 -9.87%
SJVN 35.00 -6.67%
MANAKSIA 54.35 -6.53%
TARAJEWELS 12.45 -6.04%
SUNPHARMA 525.75 -6.03%
ANIKINDS 38.30 -6.01%
GTNIND 16.95 -5.83%
DHAMPURSUG 196.30 -5.60%
More..

Vimta Labs Limited (NSE: VIMTALABS)

VIMTALABS Technical Analysis 5
As on 21st Feb 2018 VIMTALABS Share Price closed @ 208.00 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 34.46 & Strong Buy for SHORT-TERM with Stoploss of 54.01 we also expect STOCK to react on Following IMPORTANT LEVELS.
VIMTALABS Target for February
1st Target up-side 244.67
2nd Target up-side 270.13
3rd Target up-side 295.59
1st Target down-side 172.03
2nd Target down-side 146.57
3rd Target down-side 121.11
VIMTALABS Synopsis Technicals View
50 Day EMA Close is Above EMA 50 (Short Term)
Bullish
100 Day EMA Close is Above EMA 100 (Mid Term) Bullish
200 Day EMA Close is Above EMA 200 (Long Term) Bullish
MACD (12 26 9) MACD Line is Less Then SIGNAL Line Bearish
RSI (14) RSI is 57.78 Sideways
MFI (14) MFI is 50.09 Sideways
CCI (20) CCI is 7.49 Sideways
WILLIAM %R (14) William %R is -29.21 Sideways
ADX (14) ADX is Above 20 & +DI is Above -DI Up Trend
PSAR Stoploss For Short Sell 214.75
10 Day Avg Volume Traded -49.23 % Less then 10 Day Average Volume
VIMTALABS Other Details
Segment BE
Market Capital 0.00
Sector Healthcare
Industry Medical Laboratories & Research
Offical website http://www.vimta.com
VIMTALABS Address
VIMTALABS
Plot Nos.: 142/2 and 142
IDA Phase II
Hyderabad, 500051
India
Phone: 91 40 2726 4141
Fax: 91 40 2726 3657
VIMTALABS Latest News
Clarification sought from Vimta Labs Ltd   Hindu Business Line   - 18th Mar 15
Vimta Labs surges 20% on heavy volumes   Business Standard   - 13th Mar 15
Vimta Labs Ltd gets favorable verdict on service tax disputes   Equity Bulls   - 23rd Oct 14
CRISIL ratings for Indian debt instruments-Aug 12   Reuters   - 12th Aug 14
Buy Vimta Labs, Wockhardt, Allahabad Bank: Manav Chopra   Moneycontrol.com   - 07th Jul 14
Vimta Labs fails to execute Rs 30 cr projects   Business Standard   - 19th Sep 12
Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading ...   Hindu Business Line   - 09th Apr 12
Vimta Labs standalone Dec '14 sales at Rs 25.15 crore   Moneycontrol.com   - 29th Mar 12
European firm seen circling Vimta Labs   Daily News & Analysis   - 04th Jun 11
Vimta Labs Board to consider Dividend for 2009-10   Equity Bulls   - 25th Apr 10
Interactive Technical Analysis Chart Vimta Labs Limited ( VIMTALABS NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Vimta Labs Limited
VIMTALABS Business Profile
Vimta Labs Limited provides contract research and testing services primarily in India. It offers analytical testing services for food and agriculture products, and drugs and pharmaceuticals, as well as tests water samples for various purposes and specifications. The company also provides environmental assessment services, including site selection and liability studies; environmental impact assessments; environment management plans; carrying capacity based regional studies; environmental audits; solid and hazardous waste management; risk assessments and disaster management plans; occupational health and safety, industrial hygiene; environmental baseline monitoring for air, meteorology, water, soil, noise, ecology, socio-economic, demography, etc.; industrial emission source monitoring; offshore sampling and analysis of marine water and sediments; marine ecological studies; marine impact assessment; rehabilitation and resettlement studies; forestry and ecological studies; geo-technical studies; geological and hydro-geological studies; land use/ land cover studies based on remote sensing; socio-economic studies; due diligence studies; epidemiological studies; wasteland management studies; and study on bio-indicators, as well as offers various other services under environment chemistry. In addition, it provides clinical research services, including Phase-I/ bioequivalence studies, as well as screening and recruitment services; and conducts studies on arious dosage forms, such as tablets, capsules, extended release preparations, gels, jellies, transdermal patches, injectibles, etc. Further, the company offers clinical reference lab services; pre-clinical services, including drug discovery services to pharmaceutical and biotech companies in the areas of pharmacology, DMPK/ADME, toxicology, and bioanalytical; and services in the area of cell and molecular biology. Vimta Labs Limited was founded in 1984 and is based in Hyderabad, India.